A formulation platform designed to improve bioavailability, increase efficiency, and unlock the full potential of every dose.
Absorption is the limiting factor
For many oral medicines, therapeutic performance is constrained by how effectively the active compound is delivered and absorbed.
Solubility, dissolution, and formulation all play a critical role in determining how much of a dose reaches systemic circulation.
Optimising these factors represents a significant opportunity to improve outcomes without changing the underlying molecule.
A formulation-first approach
Ibumix focuses on the physical and chemical environment in which a drug is delivered.
By engineering this environment, we can influence:
- Dissolution behaviour
- Absorption kinetics
- Overall bioavailability
Technology Pillars
Advanced Formulation Engineering
Designing delivery systems that optimise how active compounds are presented and absorbed.
Next-Generation Excipients
Developing and selecting excipient systems that enhance solubility and stability.
Dissolution & Absorption Optimisation
Controlling how and when a drug becomes available for uptake.
Performance-Driven Design
Using data to iteratively refine formulation behaviour and outcomes.
From formulation to absorption
Formulation Design
Optimising composition and structure
Dissolution Behaviour
Controlling how the drug is released
Absorption Phase
Improving uptake into systemic circulation
Therapeutic Effect
Maximising effective dose delivery
Built for scale across medicines
The Ibumix approach is designed to be applied across multiple active pharmaceutical ingredients.
This creates a platform capability that extends beyond a single product, enabling:
- Application across therapeutic areas
- Adaptation to different molecular profiles
- Integration into existing pharmaceutical pipelines
Structured scientific validation
Ibumix is advancing its technology through a structured research and development programme, including collaboration with a UK academic institution.
This enables:
- Controlled experimental testing
- High-quality analytical data generation
- Independent validation of performance
Defensible by design
Ibumix is building a layered intellectual property strategy alongside its scientific development.
An initial patent application has been filed covering core aspects of the formulation approach, with additional filings planned to expand protection across applications and use cases.
This ensures that innovation is captured, protected, and positioned for long-term value creation.